Medical Oncologist
Memorial Sloan Kettering Cancer Center
I am medical oncologist at Memorial Sloan Kettering Cancer Center dedicated to developing immunotherapy for the management of sarcoma and Merkel cell carcinoma. I am specifically interested in understanding the efficacy of various immunotherapies and elucidating biomarkers predictive of response in patients with these rare tumors in partnerships with basic scientists, cooperative groups and industry. At MSK, I lead the sarcoma-specific translational research program in immunotherapy to systematically explore novel combination strategies with including, but not limited to checkpoint blockade and adoptive T-cell therapy.